WHO ICTRP trial
A multi-center, randomized, double-blind, double-simulated, positive drug…
ITMCTR2100004826 · International Traditional Medicine Clinical Trial Registry (ITMCTR) · Not Recruiting
Key facts
| Trial ID | ITMCTR2100004826 |
|---|---|
| Public title | A multi-center, randomized, double-blind, double-simulated, positive drug parallel controlled clinical trial to evaluate the effectiveness and safety of Jiuwei Zhenxin Granules in the treatment of generalized anxiety disorder |
| Scientific title | A multi-center, randomized, double-blind, double-simulated, positive drug parallel controlled clinical trial to evaluate the effectiveness and safety of Jiuwei Zhenxin Granules in the treatment of generalized anxiety disorder |
| Primary sponsor | Beijing Anding Hospital, Capital Medical University |
| Registry | International Traditional Medicine Clinical Trial Registry (ITMCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Phase | 4 |
| Countries | China |
| Conditions | Generalized Anxiety Disorder |
| Interventions | Control group:Paroxetine tablets;Experimental group:Jiuwei Zhenxin Granules |
| Registration date | Jan 28, 2021 |
| Target size | Control group:120;Experimental group:120 |
| Secondary IDs | ChiCTR2100042771;ChiMCTR2100004826 |
| Registry page | itmctr.ccebtcm.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: